Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana C Anderson

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 25, 2010
Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cellsValerie Dardalhon, Ana C Anderson, Jozsef Karman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2018
Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental GlioblastomaHiroshi Nakashima, Tran Nguyen, Kazue Kasai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
TIM-4 expressed on APCs induces T cell expansion and survivalRoselynn Rodriguez-Manzanet, Jennifer Hartt Meyers, Savithri Balasubramanian, et al.
Cell Reports. Medicine|July 3, 2024
Pan-cancer mapping of single CD8<sup>+</sup> T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunityKatherine Tooley, Livnat Jerby, Giulia Escobar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2018
Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor ImmunityKaren O Dixon, Michelle Schorer, James Nevin, et al.
Nature Communications|July 9, 2015
Corrigendum: An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunctionChen Zhu, Kaori Sakuishi, Sheng Xiao, et al.
Nature Communications|January 24, 2015
An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunctionChen Zhu, Kaori Sakuishi, Sheng Xiao, et al.
Nature Immunology|October 12, 2023
Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammationAlexandra Schnell, Linglin Huang, Brianna M L Regan, et al.
Science (New York, N.Y.)|November 17, 2007
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cellsAna C Anderson, David E Anderson, Lisa Bregoli, et al.
Science Immunology|March 11, 2022
Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell functionRuihan Tang, Nandini Acharya, Ayshwarya Subramanian, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|June 25, 2010
Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cellsValerie Dardalhon, Ana C Anderson, Jozsef Karman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2018
Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental GlioblastomaHiroshi Nakashima, Tran Nguyen, Kazue Kasai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
TIM-4 expressed on APCs induces T cell expansion and survivalRoselynn Rodriguez-Manzanet, Jennifer Hartt Meyers, Savithri Balasubramanian, et al.
Cell Reports. Medicine|July 3, 2024
Pan-cancer mapping of single CD8<sup>+</sup> T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunityKatherine Tooley, Livnat Jerby, Giulia Escobar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2018
Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor ImmunityKaren O Dixon, Michelle Schorer, James Nevin, et al.
Nature Communications|July 9, 2015
Corrigendum: An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunctionChen Zhu, Kaori Sakuishi, Sheng Xiao, et al.
Nature Communications|January 24, 2015
An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunctionChen Zhu, Kaori Sakuishi, Sheng Xiao, et al.
Nature Immunology|October 12, 2023
Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammationAlexandra Schnell, Linglin Huang, Brianna M L Regan, et al.
Science (New York, N.Y.)|November 17, 2007
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cellsAna C Anderson, David E Anderson, Lisa Bregoli, et al.
Science Immunology|March 11, 2022
Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell functionRuihan Tang, Nandini Acharya, Ayshwarya Subramanian, et al.
Pageof 11